发明名称 |
USE OF INHIBITORS OF EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)/PROSTATIC HYPERTROPHY |
摘要 |
The present invention relates to the use of specific EGF-receptor antagonists for preparing a pharmaceutical composition for the prevention and/or treatment of benign prostatic hyperplasia and / or prostatic hypertrophy, a method for the treatment or prevention of benign prostatic hyperplasia / prostatic hypertrophy comprising administering an EGF-receptor antagonist of groups (A), (B) or (C), optionally in combination with known compounds for the treatment of benign prostatic hyperplasia / prostatic hypertrophy, as well as associated pharmaceutical compositions.
|
申请公布号 |
CA2483590(C) |
申请公布日期 |
2011.01.04 |
申请号 |
CA20032483590 |
申请日期 |
2003.05.02 |
申请人 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
发明人 |
SINGER, THOMAS;COLBATZKY, FLORIAN;PLATZ, STEFAN |
分类号 |
A61K31/517;A61K39/395;A61K31/47;A61K31/4706;A61K31/519;A61K31/5377;A61P13/08 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|